Radiology
Sinovac Schedules 2010 Annual Meeting of Shareholders
June 18, 2010 8:37 am | by Bio-Medicine.Org | News | CommentsBEIJING , June 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines in China , announced today that it will hold its 2010 Annual Meeting of Shareholders on Thursday, July 15, 2010 at 9:00 a.m. Beijing Time. The meeting will be held...
Naviscan Positron Emission Mammography Technology Highlighted at the Society of Nuclear Medicine Annual Meeting
June 18, 2010 8:37 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO , June 18 /- Naviscan's Positron Emission Mammography (PEM) technology was the focus of several presentations and discussions at the Society of Nuclear Medicine Annual Meeting in Salt Lake City . The focus represents a growing interest and validation of how PEM can play an...
ProUroCare Medical Secures $885,000 in Financing
June 17, 2010 6:35 am | by Bio-Medicine.Org | News | CommentsMINNEAPOLIS , June 17 /- ProUroCare Medical, Inc. (OTC Bulletin Board: PUMD), a provider of proprietary imaging products, today announced that it has closed on a $885,000 private placement of debt financing. Â The funding was provided by a small group of existing investors closely...
Renhuang Wins Bid to Supply All-Natural Products to Guangzhou Military District
June 17, 2010 6:35 am | by Bio-Medicine.Org | News | CommentsHARBIN, China , June 17 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that on...
Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
June 17, 2010 6:34 am | by Bio-Medicine.Org | News | CommentsBASKING RIDGE, N.J. , June 17 /- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo , PhD, President and CEO, will be presenting at the 2010 Wells Fargo Healthcare Conference at the...
TIBCO Introduces Spotfire® Clinical To Improve Clinical Trials And Accelerate Drug Development
June 17, 2010 1:36 am | by RealWire | News | CommentsNew Analytics Solution Integrates with Leading Clinical Development Systems and Supports Clinical Data Monitoring, Clinical Safety, and Clinical Operations AnalyticsLondon - June 17, 2010 - TIBCO Software Inc. (NASDAQ: TIBX) today announced the launch of TIBCO Spotfire® Clinical,...
FDA Cautions on Accurate Vitamin D Supplementation for Infants
June 15, 2010 9:40 am | by Bio-Medicine.Org | News | CommentsSILVER SPRING, Md. , June 15 /PRNewswire-USNewswire/ -- The Food and Drug Administration today alerted parents and caregivers that some liquid Vitamin D supplement products are sold with droppers that could allow excessive dosing of Vitamin D to infants. (Logo: ...
DHL Global Mail Launches Specialized Shipping Service for Mail-Order Pharmacies
June 15, 2010 9:40 am | by Bio-Medicine.Org | News | CommentsWESTON, Fla. , June 15 /- DHL Global Mail today launched a new shipping service designed specifically around the needs of mail-order pharmacies. DHL SMARTMAIL PHARMA SELECT ™ incorporates best practices the mail expediter has established over many years of serving the pharmaceutical...
Healthy Adviceâ„¢ Networks Physicians Participate in Panel at Sales Force Effectiveness Conference
June 15, 2010 9:40 am | by Bio-Medicine.Org | News | CommentsCINCINNATI , June 15 /- Healthy Advice ™ Networks, the nation's leading provider of points-of-care health-education programs for consumers and physicians, hosted a panel of their physicians at the recent eyeforpharma Sales Force Effectiveness Conference held in Princeton, New Jersey...
Florida woman sues DePuy Orthopedics over hip implant
June 15, 2010 7:38 am | by Mass Device | News | CommentsA Florida woman sues Johnson & Johnson subsidiary DePuy Orthopedics, alleging that her ASR metal-on-metal hip replacement was defective and accusing the company of knowing about the device's problems but failing to warn physicians. DePuy Orthopaedics is facing the...
New President and Chief Executive Officer Named at Access Communications, LLC
June 15, 2010 6:40 am | by Bio-Medicine.Org | News | CommentsBERKELEY HEIGHTS, N.J. , June 15 /- Access Communications, LLC (Access) has named David P. Gagliano the company's president and chief executive officer (CEO). Since mid-2009, Access was under the leadership of a group of managing partners, a role in which Gagliano served in addition to...
Access Communications, LLC Wins Four Creative Design Awards from the Art Directors Club of New Jersey
June 15, 2010 6:40 am | by Bio-Medicine.Org | News | CommentsBERKELEY HEIGHTS, N.J. , June 15 /- Access Communications, LLC (Access) has been awarded four distinctions of honor for its creative expertise from the Art Directors Club of New Jersey (ADCNJ). The most notable ADCNJ recognition for 2009 is the agency's Medal Award for the creative design...
Perrigo Company to Present at the 31st Annual Goldman Sachs Global Healthcare Conference
June 15, 2010 6:39 am | by Bio-Medicine.Org | News | CommentsALLEGAN, Mich. , June 15 /- Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Executive Vice President and CFO Judy Brown will present at the 31st Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 15 , at 3:05 p.m. (PT) at the Hyatt Regency Century Plaza...
Healthcare matchmaker WellClicks raises $1 million
June 15, 2010 6:39 am | by Mass Device | News | CommentsWellClicks, a startup aiming to connect consumers with healthcare providers that match their preferences, drums up $1 million in an equity offering. By Brandon Glenn WellClicks, a startup that promises to match consumers with health providers, raised $1 million from seven...
Surplus PC Power Yields Faster Cancer Research
June 15, 2010 4:42 am | by IBM | News | CommentsScientists have devised a way to automate and accelerate a manual, complex process that enables researchers to more easily discover the structure of cancer-related proteins, and, eventually, formulate cancer cures. This new, automated approach may also help the exploration of other...
Cleveland Clinic invests in company that helps patients shop for care
June 11, 2010 1:39 pm | by Mass Device | News | CommentsThe Cleveland Clinic makes an investment in California internet search engine company Castlight Health Inc. to push transparency in healthcare pricing by offering consumers way to find cheaper care. By Mary Vanac Already an outspoken advocate for healthy living as a means to...
Zargis licenses Stethographics' lung sounds analysis tool
June 11, 2010 7:40 am | by Mass Device | News | CommentsZargis Medical Corp. licenses Stethographics Inc.'s auscultation analysis technology for its telemedicine and computer-aided auscultation platform. Zargis Medical Corp. licensed Stethographics Inc.'s lung sounds analysis technology for its telemedicine platform. The...
Smith & Nephew names Interlace Medical CTO in patent infringement suit
June 11, 2010 5:39 am | by Mass Device | News | CommentsSmith & Nephew Inc.'s patent infringement lawsuit against Interlace Medical Inc. accuses Interlace Medical Inc. CTO Ronald Adams of bringing the technology with him when he left the British medical products conglomerate in 2006. Smith & Nephew Inc. (NYSE:SNN) hit...
MassDevice Q & A: John Abele, Part II
June 10, 2010 10:38 am | by Mass Device | News | CommentsBoston Scientific Corp. co-founder John Abele, in the second installment of a lengthy interview, on the early days with Peter Nicholas, his take on demands for increased...
Protein E-selectin ligand-1 regulates production of TGF-beta
June 9, 2010 2:38 pm | by Baylor College of Medicine | News | CommentsSeveral years ago, Dr. Arthur Beaudet , Baylor College of Medicine's chair of molecular and human genetics, was surprised to find that mice that lacked a protein called E-selectin ligand-1 were shorter than normal. He and his colleagues were hoping that the protein was involved in cell...
VCs: Healthcare reform won't impede med-tech investment
June 9, 2010 12:37 pm | by Mass Device | News | CommentsAn informal survey of venture capital investors reveals their lack of worry that the healthcare reform act will slow down investment in medical technology. Readers of this website, and this blog, are likely to have a special interest in the business impacts of healthcare legislative...
Tennessee judge rules no preemption in Stryker hip implant suit
June 8, 2010 5:41 am | by Mass Device | News | CommentsA federal judge in Tennessee rules that preemption does not apply in a product liability lawsuit over a Stryker Corp. hip implant. A federal judge in Tennessee ruled that preemption does not apply in the case of a product liability lawsuit over an allegedly defective Stryker...
Report: Reimbursement codes block innovative surgical techniques
June 7, 2010 1:40 pm | by Mass Device | News | CommentsCommercialization costs and bureaucratic red tape keep device makers from bringing more advanced minimally invasive surgical techniques into the spectrum of care, according to a report from design and engineering firm Cambridge Consultants. Entrepreneurs in the minimally...
Karmanos Cancer Institute Researchers Study Bisphosphonates and Their Affect on Early Stage Breast Cancer
June 5, 2010 11:38 am | by Bio-Medicine.Org | News | CommentsCHICAGO , June 5 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented preliminary data that shows nitrogen-containing bisphosphonates, therapeutic agents used to promote bone health and inhibit resorption, may cause a slightly poorer...
Onyx Pharmaceuticals Presents Interim Results of Phase 1b Carfilzomib Combination Trial
June 4, 2010 12:41 pm | by Bio-Medicine.Org | News | CommentsEMERYVILLE, Calif. , June 4 /- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced updated interim results of the Phase 1b dose-escalation trial, known as the 006 study, evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients...
